[ad_1]
“The vaccine supply is relatively fluid, and it involves many but one manufacturers. Unfortunately, the volumes supplied by this producer do not meet the previously agreed obligations, so we must do everything possible to improve the situation, “said the Lithuanian leader after the European Council meeting on Thursday.
The European Commission strengthened its vaccine export control mechanism on Wednesday to prevent what is called an unfair departure of vaccines from the Community. The Commission will henceforth assess the incidence and number of vaccines available in the countries to which vaccines are exported from the EU, as well as their willingness to ship vaccines and vaccine components to the Community.
The measure will restrict the export of vaccines to countries such as the United Kingdom, which produces some of its vaccines but does not send them to the EU.
EU officials emphasized that the new system was not a “vaccine export ban” and was not directed against any particular country, although they recalled that AstraZeneca, a UK-based company, had not fulfilled all its obligations to supply medicines to Europe.
According to G. Nausėda, this is “an appropriate measure in view of the tense situation.”
According to the head of state, Lithuania is currently among the countries that receive “relatively more vaccines” because “we have adequately distributed our portfolio of producers.”
“The offer is really satisfactory in the vast majority of cases. (…) The target of 70% vaccination at the EU level adult population until the end of the summer – they remain. Lithuania may be among those countries that can do it even a little earlier, “said the president.
G. Nausėda has previously said that Lithuania’s goal is to achieve public immunity for State Day, July 6.
According to data from the Department of Statistics, at least the first dose has been vaccinated to more than 300 thousand. population, almost 11 percent. of the entire population of the country.
